Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Hologic (HOLX) PT Raised to $43 at Canaccord Genuity
-
Hologic (HOLX) PT Lowered to $41 at Canaccord Genuity
-
Hologic to Webcast Presentation at the Canaccord Genuity 38th Annual Growth Conference
-
Canaccord Genuity Downgrades Hologic (HOLX) to Hold
-
Hologic (HOLX) PT Lowered to $48 at Canaccord Genuity Following 1Q Results
-
Hologic (HOLX) PT Lowered to $44 at Canaccord Genuity
-
Hologic to Webcast Presentations at Upcoming Investor Conferences
-
Hologic to Webcast Presentations at Upcoming Investor Conferences
-
Hologic to Webcast Presentations at Upcoming Investor Conferences
-
Hologic to Present at Upcoming Investor Conferences
-
Canaccord Genuity Raises Price Target on Hologic (HOLX) Following 3Q Beat and FY15 Guidance Raise
-
Notable Analyst Rating Changes 7/24: (UAL) (SCTY) (DIS) Upgraded; (IAG) (CF) (ABAX) Downgraded
-
Hologic (HOLX) PT Boosted to $40 at Canaccord Genuity Following Meetings
-
UPDATE: Canaccord Genuity Upgrades Hologic (HOLX) to Buy; Survey 'Overwhelmingly Positive'
-
Notable Analyst Rating Changes 07/17: (MDVN) (ADBE) (LINE) Upgraded; (AXP) (HOLX) (PAAS) Downgraded
-
Analysts Say Hologic (HOLX) Guidance Conservative
-
Canaccord Genuity Boosts Target on Hologic (HOLX) on Positive Risk/Reward
-
Canaccord Genuity Maintains a 'Buy' on Hologic (HOLX); Looking for a Dip
-
Streetinsider.com's Hot Lunchtime Reads 07/26: (AAPL) (AKAM) (GNC) (SWI) (WDC) (MSFT)
-
Canaccord Genuity Suggests Buying Hologic (HOLX) on Weakness After Mixed Q3 Pre-Announcement